Quantcast

Latest Bayer HealthCare Stories

2014-10-01 12:24:34

-- Bayer becomes the OTC leader in North and Latin America and achieves top global positions in key OTC categories -- Erica Mann heads Bayer's new consumer care business globally -- Course set for successful integration -- Strategic pharma collaboration between Bayer und Merck & Co., Inc. in the field of sGC modulators takes effect TORONTO, Oct. 1, 2014 /CNW/ - Bayer has completed the global acquisition of the consumer care business of the U.S....

2014-09-22 04:21:43

TARRYTOWN, N.Y., Sept. 22, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for EYLEA(®) (aflibercept) Injection for myopic choroidal neovascularization (myopic CNV). EYLEA has already been approved in Japan for the treatment of patients with neovascular age-related macular degeneration (wet AMD), and...

2014-09-04 04:21:42

TARRYTOWN, N.Y., Sept. 4, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd. has submitted a marketing authorization application for EYLEA(®) (aflibercept) Injection for macular edema following branch retinal vein occlusion (BRVO) to the Japanese Ministry of Health, Labour and Welfare (MHLW). EYLEA has already been approved in Japan for the treatment of patients with neovascular (wet)...

2014-07-29 08:32:14

Brand Teams Up with Actor and Comedian Joel McHale to Introduce Berocca and Kick off "Get A Lift, Give A Lift" WHIPPANY, N.J., July 29, 2014 /PRNewswire/ -- Excitement is bubbling up nationwide and it's all about the fizz. Today, Bayer HealthCare announces the nationwide arrival of Berocca - an energy support supplement in an effervescent tablet that, when dropped into a glass of water, unleashes a fizzy, refreshing, infusion of key ingredients that support mental sharpness and...

2014-06-27 08:24:46

TARRYTOWN, N.Y., June 27, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA(®) (aflibercept) Injection has been recommended for approval by the European Committee for Medicinal Products for Human Use (CHMP) for the treatment of visual impairment due to diabetic macular edema (DME). The decision of the European Commission is expected in the second half of 2014. "Diabetes is a growing health concern worldwide and this milestone brings us...

2014-06-23 08:27:25

LEVERKUSEN, Germany, June 23, 2014 /PRNewswire/ -- Bayer HealthCare (Bayer) and Dimension Therapeutics, a company focused on developing novel adeno-associated virus (AAV) gene therapy treatments for rare diseases, have entered into a collaboration for the development and commercialization of a novel gene therapy for the treatment of hemophilia A. "Bayer is a worldwide leader in the treatment of hemophilia A and we are highly committed to advancing innovative treatment options for...

2014-06-11 04:21:59

TARRYTOWN, N.Y., June 11, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA(®) (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO). The EMA submission is based on the positive Phase 3 VIBRANT trial, a double-masked,...

2014-05-14 08:32:01

- Bayer HealthCare joins internet portal www.clinicalstudydatarequest.com LEVERKUSEN, Germany, May 14, 2014 /PRNewswire/ -- Bayer HealthCare announced today that it will start sharing data from its clinical studies through the internet portal www.clinicalstudydatarequest.com. From now on, qualified researchers can request anonymized patient-level data from Bayer HealthCare sponsored clinical studies listed on the website. http://photos.prnewswire.com/prnvar/20140312/NY79226LOGO...

2014-05-06 08:32:51

Move to significantly strengthen position in consumer care LEVERKUSEN, Germany, May 6, 2014 /PRNewswire/ -- Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA, for a purchase price of USD 14.2 billion (EUR 10.4 billion). "This acquisition marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business," explained Bayer CEO Dr. Marijn...

2014-05-01 08:37:16

Charitable Campaign Urges Women to Help Prepare for a Heart Attack by Including Bayer® Aspirin in Their Handbags WHIPPANY, N.J., May 1, 2014 /PRNewswire/ -- Each year in the U.S., nearly 300,000 women have heart attacks,(i) yet most women's handbags are better prepared to manage a broken nail (55%) or bad hair day (36%) than a heart attack (17%).(ii) Today, Bayer HealthCare, the makers of Bayer® Aspirin and WomenHeart: The National Coalition for Women with Heart Disease announce...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related